Dr. Daryoush Shahbazi-Gahrouei
My Social Links

Dr. Daryoush Shahbazi-Gahrouei

Professor
Isfahan University of Medical Sciences, Iran

Highest Degree
Ph.D. in Medical Physics from University of Western Sydney, Australia

Share this Profile

Biography

Dr. Daryoush Shahbazi-Gahrouei has completed his Ph.D. in Medical Physics from University of Western Sydney, Australia. He holds the position of Professor of Medical Physics at the Department of Medical Physics and Medical Engineering in the School of Medicine of Isfahan University of Medical Sciences, Iran. He has authored more than 106 papers in the area of Medical Physics, including of Novel Nanoparticles as MR Imaging Contrast Agents for Cancer Detection, Natural Radiation, Nuclear Medicine, Medical Imaging, effects of Electromagnetic Fields, Radiation Protection, Advanced Radiation Therapy and Radiation Dosimetry. Dr. Daryoush received honor includes award for Excellence in University Research, Isfahan University of Medical Sciences, Isfahan, Iran, Travel Grant, Second Non Ionizing Radiation Safety Conference. Shiraz. Iran, award for Excellence in University Research, Shahrekord University of Medical Sciences, Shahrekord, Iran, and Ravel Award, Ministry of Health and Medical Education, Tehran, Iran.

Area of Interest:

Biomedical Sciences
100%
Biotechnology
62%
Environmental Biotechnology
90%
Molecualar Biology
75%
Marine Biotechnology
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Raeisi, F., D. Shahbazi-Gahrouei, E. Raeisi and E. Heidarian, 2019. Evaluation of the radiosensitizing potency of bromelain for radiation therapy of 4T1 breast cancer cells. J. Med. Signals Sens., 9: 68-74.
    CrossRef  |  Direct Link  |  
  2. Maziar, A., R. Paydar, G. Azadbakht and D. Shahbazi-Gahrouei, 2019. Estimation of absorbed dose of the thyroid gland in patients undergoing 64-slice head computed tomography and comparison the tesults with ImPACT software and computed tomography scan dose index. J. Med. Signals Sens., (In Press). 10.4103/jmss.JMSS_40_18.
    CrossRef  |  
  3. Karimi, A.H., H. Brkic, D. Shahbazi-Gahrouei, S.B. Haghighi and I. Jabbari, 2019. Essential considerations for accurate evaluation of photoneutron contamination in radiotherapy. Applied Radiat. Isotopes, 145: 24-31.
    CrossRef  |  
  4. Shahbazi-Gahrouei, D., S.S. Setayandeh, F. Aminolroayaei and S. Shahbazi-Gahrouei, 2018. Biological effects of non-ionizing electromagnetic fields on human body and biological system: A systematic literature review. J. Med. Sci., 18: 149-156.
    CrossRef  |  Direct Link  |  
  5. Shahbazi-Gahrouei, D., B. Hashemi-Beni, A. Moradi, M. Aliakbari and S. Shahbazi-Gahrouei, 2018. Exposure to global system for mobile communication 900 mhz cellular phone radiofrequency alters growth, proliferation and morphology of michigan cancer foundation-7 cells and mesenchymal stem cells. Int. J. Preventive Med., Vol. 9. 10.4103/ijpvm.IJPVM_75_17.
    CrossRef  |  
  6. Saeb, M., D. Shahbazi-Gahrouei and S. Monadi, 2018. Evaluation of targeted image-guided radiation therapy treatment planning system by use of American association of physicists in medicine task group-119 test cases. J. Med. Signals Sens., 8: 95-100.
    PubMed  |  Direct Link  |  
  7. Raeisi, F., E. Raeisi, D. Shahbazi-Gahrouei, E. Heidarian and M. Amiri, 2018. Comparison of the radiosensitivity of cancer and normal cells to x-ray irradiation using MTT assay: An in-vitro study. J. Isfahan Med. Sch., 36: 246-250.
  8. Nazem, M., D. Shahbazi-Gahrouei, M.R. Sharbafchi, M.S. Jafarpishe and M. Hosseinpour, 2018. Evaluation of cumulative radiation dose in neonates in neonatal surgery ward of Alzahra hospital of Isfahan. Iran. J. Pediatr. Surg., 4: 71-79.
    CrossRef  |  
  9. Keshtkar, M., D. Shahbazi-Gahrouei, M.A. Mehrgardi, M. Aghaei and S.M. Khoshfetrat, 2018. Synthesis and cytotoxicity assessment of gold-coated magnetic iron oxide nanoparticles. J. Biomed. Phys. Eng., 8: 357-364.
    CrossRef  |  
  10. Keivan, H., D. Shahbazi-Gahrouei, A. Shanei and A. Amouheidari, 2018. Assessment of imprecise small photon beam modeling by two treatment planning system algorithms. J. Med. Signals Sens., 8: 39-45.
    PubMed  |  Direct Link  |  
  11. Keivan, H., D. Shahbazi-Gahrouei and A. Shanei, 2018. Evaluation of dosimetric characteristics of diodes and ionization chambers in small megavoltage photon field dosimetry. Int. J. Radiat. Res., 16: 311-321.
  12. Karbalaee, M., D. Shahbazi-Gahrouei and M.B. Tavakoli, 2018. A novel GPU-based fast Monte Carlo photon dose calculating method for accurate radiotherapy treatment planning. J. Biomed. Phys. Eng. 10.22086/jbpe.v0i0.716.
    CrossRef  |  Direct Link  |  
  13. Gholami, M. and D. Shahbazi-Gahrouei, 2018. The effect of gel homogeneity on dose response in a low-density polymer gel dosimeter for radiation therapy. J. Cancer Res. Ther., 14: 563-566.
    CrossRef  |  Direct Link  |  
  14. Ghahremani, F., D. Shahbazi-Gahrouei, A. Kefayat, H. Motaghi, M.A. Mehrgardi and S.H. Javanmard, 2018. AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells. RSC Adv., 8: 4249-4258.
    CrossRef  |  Direct Link  |  
  15. Ghahremani, F., A. Kefayat, D. Shahbazi-Gahrouei, H. Motaghi, M.A. Mehrgardi and S. Haghjooy-Javanmard, 2018. AS1411 aptamer-targeted gold nanoclusters effect on the enhancement of radiation therapy efficacy in breast tumor-bearing mice. Nanomedicine, 13: 2563-2578.
    CrossRef  |  Direct Link  |  
  16. Fazel-Ghaziyani, M., M. Pourhassan-Moghaddam, D. Shahbazi-Gahrouei, M. Ghavami, A. Mohammadi, M.M. Abbasi and B. Baradaran, 2018. Anti-CD24 bio modified PEGylated gold nanoparticles as targeted computed tomography contrast agent. Adv Pharm. Bull., 8: 599-607.
    CrossRef  |  
  17. Fazel-Ghaziyani, M., D. Shahbazi-Gahrouei, M. Pourhassan-Moghaddam, B. Baradaran and M. Ghavami, 2018. Targeted detection of the cancer cells using the anti-CD24 bio modified PEGylated gold nanoparticles: The application of CD24 as a vital cancer biomarker. Nanomed. J., 5: 172-179.
    CrossRef  |  Direct Link  |  
  18. Emami, H., A.A. Shakeri, A. Akhavan, D. Shahbazi-Gahrouei and P. Akbari, 2018. Effect of livergol on the improvement of fatty liver in patients with cancer undergoing irinotecan- and oxaliplatin-based chemotherapy regimen. J. Res. Med. Sci., Vol. 23. 10.4103/jrms.JRMS_793_17.
    CrossRef  |  
  19. Aliasgharzadeh, A., D. Shahbazi-Gahrouei and F. Aminolroayaei, 2018. Radiation cancer risk from doses to newborn infants hospitalized in neonatal intensive care units in children hospitals of Isfahan province. Int. J. Radiat. Res., 16: 117-122.
    Direct Link  |  
  20. Sharifian, S. and D. Shahbazi-Gahrouei, 2017. Dose assessment in multidetector computed tomography (CT) of polymethylmethacrylate (PMMA) phantom using American association of physicists in medicine-task group report no. 111 (AAPM-TG111). J. Isfahan Med. Sch., 35: 200-205.
  21. Shahbazi-Gahrouei, D., S. Razavi, F. Koosha and M. Salimi, 2017. Exposure of Extremely-Low Frequency (ELF) magnetic field may cause human cancer. Acta Med. Int., 4: 32-39.
    CrossRef  |  Direct Link  |  
  22. Shahbazi-Gahrouei, D., M. Saeb, S. Monadi and I. Jabbari, 2017. Clinical implications of TiGRT algorithm for external audit in radiation oncology. Adv. Biomed. Res., Vol. 6. 10.4103/abr.abr_268_16.
    CrossRef  |  
  23. Shahbazi-Gahrouei, D., B. Changizi, A. Jomehzadeh and M.H. Larizadeh, 2017. The effect of contrast media on treatment planning and dose calculation in radiation therapy of pelvis cancers. J. Isfahan Med. Sch., 34: 1389-1394.
  24. Shahbazi-Gahrouei, D., A. Gookizadeh, M. Sohrabi and Z. Arab-Bafrani, 2017. Chest dose assessment in breast cancer therapy using two electron energies. J. Isfahan Med. Sch., 35: 796-800.
  25. Shahbazi-Gahrouei, D., 2017. Does 900-MHz mobile phone radiation affect proliferation rate and viability of human-adipose-derived stem cells? J. Isfahan Med. Sch., 35: 84-86.
  26. Shahbazi-Gahrouei, D., 2017. Base transceiver station antennae exposure and human health. Int. J. Preventive Med., Vol. 8. 10.4103/ijpvm.IJPVM_180_17.
    CrossRef  |  
  27. Saberi, A., D. Shahbazi-Gahrouei, M. Abbasian, M. Fesharaki, A. Baharlouei and Z. Arab-Bafrani, 2017. Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells. Int. J. Radiat. Biol., 93: 315-323.
    CrossRef  |  
  28. Raeisi, F., E. Raeisi, D. Shahbazi-Gahrouei, E. Heidarian and F. Amini, 2017. A comparison of Thiazolyl blue (MTT) versus Sulforhodamine B (SRB) assay in assessment of antiproliferation effect of bromelain on 4T1, AGS and PC3 cancer cell lines. J. Isfahan Med. Sch., 35: 1056-1061.
  29. Koohian, F., A. Shanei, D. Shahbazi-Gahrouei, S.H. Hejazi, A. Ahmadi and M.R. Sharifi, 2017. The effect of resveratrol administration in irradiated mice on the induction of micronuclei in bone marrow. J. Radiat. Oncol., 6: 423-427.
    CrossRef  |  
  30. Koohian, F., A. Shanei, D. Shahbazi-Gahrouei, S.H. Hejazi and M.T. Moradi, 2017. The radioprotective effect of resveratrol against genotoxicity induced by γ-irradiation in mice blood lymphocytes. Dose-Response, Vol. 15. 10.1177/1559325817705699.
    CrossRef  |  Direct Link  |  
  31. Khaniabadi, P.M., D. Shahbazi-Gahrouei, M.S. Jaafar, A.M.S. Abdul Majid, B.M. Khaniabadi and S. Shahbazi-Gahrouei, 2017. Magnetic iron oxide nanoparticles as T2 MR imaging contrast agent for detection of breast cancer (MCF-7) cell. Avicenna J. Med. Biotechnol., 9: 181-188.
    PubMed  |  Direct Link  |  
  32. Khaniabadi, P.M., D. Shahbazi-Gahrouei, A.M.S. Abdul Majid, M.S. Jaafar, B.M. Khaniabadi and S. Shahbazi-Gahrouei, 2017. In vitro study of SPIONs-C595 as molecular imaging probe for specific breast cancer (MCF-7) cells detection. Iran. Biomed. J., 21: 360-368.
    CrossRef  |  PubMed  |  Direct Link  |  
  33. Khaniabadi, P.M., A.M.S. Abdul Majid, M. Asif, B.M. Khaniabadi, D. Shahbazi-Gahrouei and M.S. Jaafar, 2017. Breast cancer cell targeted MR molecular imaging probe: Anti-MUC1 antibody-based magnetic nanoparticles. J. Phys.: Conf. Ser., Vol. 851. 10.1088/1742-6596/851/1/012014.
    CrossRef  |  Direct Link  |  
  34. Karbalaee, M., D. Shahbazi-Gahrouei and M.B. Tavakoli, 2017. An approach in radiation therapy treatment planning: A fast, GPU-based Monte Carlo method. J. Med. Signals Sens., 7: 108-113.
    PubMed  |  Direct Link  |  
  35. Jomehzadeh, A., D. Shahbazi-Gahrouei and V. Jahanbakhsh, 2017. Effect of material and wall thickness buildup caps on the head scatter factor measurements in irregular fields shielded by cerrobend. J. Med. Signals Sens., 7: 247-251.
    PubMed  |  Direct Link  |  
  36. Hashmi-Beni, B., A. Moradi, D. Shahbazi-Gahrouei and M. Aliakbari, 2017. The effects of 900 MHz mobile telephone radiation on survival and proliferation rate of breast cancer MCF-7 cells: An in-vitro study. J. Isfahan Med. Sch., 34: 1475-1480.
    Direct Link  |  
  37. Baradaran-Ghahfarokhi, M., A. Amouheidari, D. Shahbazi-Gahrouei, H. Baradaran-Ghahfarokhi, T. Kari, D. Wolfgang and P. Shokrani, 2017. Evaluation of the effects of prostate radiotherapy on occludin expression and ultrasonography characteristics of the bladder. Int. J. Radiat. Oncol. Biol. Phys., 99: 963-971.
  38. Arabpour, A. and D. Shahbazi-Gahrouei, 2017. Effect of hypofractionation on prostate cancer radiotherapy. Int. J. Cancer Manage., Vol. 10. 10.5812/ijcm.12204.
    CrossRef  |  Direct Link  |  
  39. Arab-Bafrani, Z., D. Shahbazi-Gahrouei and M. Abbasian, 2017. Rapid delivery of gold nanoparticles into colon cancer HT-29 cells by electroporation: In-vitro study. J. Biomed. Phys. Eng., 10.22086/jbpe.v0i0.579.
    CrossRef  |  Direct Link  |  
  40. Zahraei, M., M. Marciello, A. Lazaro-Carrillo, A. Villanueva and F. Herranz et al., 2016. Versatile theranostics agents designed by coating ferrite nanoparticles with biocompatible polymers. Nanotechnology, Vol. 27. Nanotechnology, Vol. 27. 10.1088/0957-4484/27/25/255702.
    CrossRef  |  Direct Link  |  
  41. Shahbazi-Gahrouei, D., M.R. Abdi, A. Paknejad and M. Baradaran-Ghahfarokhi, 2016. Evaluation of absorbed dose from common radiology examinations in Yasuj, Iran using experimental measurement and Monte Carlo calculations. J. Isfahan Med. Sch., 34: 106-113.
  42. Shahbazi-Gahrouei, D., M. Damoori, M.B. Tavakoli and M. Moslehi, 2016. Comparison of accuracy in calculation of absorbed dose to patients following bone scan with 99mTc-marked diphosphonates by two different background correction methods. J. Med. Signals Sens., 6: 33-38.
    PubMed  |  
  43. Shahbazi-Gahrouei, D., M. Asgarian, S. Setayeshi and S. Jafari, 2016. The influence of low-frequency electromagnetic fields (ELFs) on MCF-7 cancer cells. J. Isfahan Med. Sch., 33: 2137-2142.
  44. Shahbazi-Gahrouei, D., L. Shiri, H. Alaei and N. Naghdi, 2016. The effect of continuous ELF-MFs on the level of 5-HIAA in the raphe nucleus of the rat. J. Radiat. Res., 57: 127-132.
    CrossRef  |  Direct Link  |  
  45. Shahbazi-Gahrouei, D., B. Hashemi-Beni and Z. Ahmadi, 2016. Effects of RF-EMF exposure from GSM mobile phones on proliferation rate of human adipose-derived stem cells: An in-vitro study. J. Biomed. Phys. Eng., 6: 243-252.
    PubMed  |  Direct Link  |  
  46. Shahbazi-Gahrouei, D. and M. Keshtkar, 2016. Magnetic nanoparticles and cancer treatment. Immunopathol. Persa, Vol. 2. .
    Direct Link  |  
  47. Rezaee, V., D. Shahbazi-Gahrouei, S. Monadi and M. Saeb, 2016. Evaluation of error doses of treatment planning software using solid anthropomorphic phantom. J. Isfahan Med. Sch., 34: 908-913.
  48. Raeisi, F., E. Raeisi, D. Shahbazi-Gahrouei, E. Heidarian, M. Amiri and M. Gholami-Arjenaki, 2016. Cytotoxicity effect of pineapple extract on breast cancer cells (4T1). J. Isfahan Med. Sch., 34: 946-951.
    Direct Link  |  
  49. Raeisi, E., D. Shahbazi-Gahrouei and E. Heidarian, 2016. Pineapple extract as an efficient anticancer agent in treating human cancer cells. Persian J. Front. Cancers, Vol. 1. .
    Direct Link  |  
  50. Mortazavi, S.M.J., A. Zahiri, D. Shahbazi-Gahrouei, S. Sina and M. Haghani, 2016. Designing a shield with lead-free polymer base with high radiation protection for X-ray photons in the range of diagnostic radiology using Monte Carlo simulation code MCNP5. J. Isfahan Med. Sch., 34: 637-641.
  51. Maziar, A., D. Shahbazi-Gahrouei, M.B. Tavakoli, V. Changizi and Z. Ghasemian, 2016. Detection of breast cancer using non-invasive X-ray diffraction technique of hair: A preliminary study. Int. J. Radiat. Res., 14: 153-158.
  52. Keshtkar, M., D. Shahbazi-Gahrouei, S.M. Khoshfetrat, M.A. Mehrgardi and M. Aghaei, 2016. Aptamer-conjugated magnetic nanoparticles as targeted magnetic resonance imaging contrast agent for breast cancer. J. Med. Signals Sens., 6: 243-247.
    PubMed  |  Direct Link  |  
  53. Arab-Bafrani, Z., D. Shahbazi-Gahrouei, M. Abbasian, A. Saberi, M. Fesharaki, S.H. Hejazi and S. Manshaee, 2016. Culturing in serum-free culture medium on collagen type-I-coated plate increases expression of CD133 and retains original phenotype of HT-29 cancer stem cell. Adv. Biomed. Res., Vol. 5. 10.4103/2277-9175.179181.
    CrossRef  |  PubMed  |  Direct Link  |  
  54. Arab-Bafrani, Z., D. Shahbazi-Gahrouei, M. Abbasian and M. Fesharaki, 2016. Multiple MTS assay as the alternative method to determine survival fraction of the irradiated HT-29 colon cancer cells. J. Med. Signals Sens., 6: 112-116.
    PubMed  |  
  55. Zahraei, M., A. Monshi, M.D.P. Morales, D. Shahbazi-Gahrouei, M. Amirnasr and B. Behdadfar, 2015. Hydrothermal synthesis of fine stabilized superparamagnetic nanoparticles of Zn2+ substituted manganese ferrite. J. Magnetism Magnetic Mater., 393: 429-436.
    CrossRef  |  Direct Link  |  
  56. Zahraei, M., A. Monshi, D. Shahbazi-Gahrouei, M. Amirnasr, B. Behdadfar and M. Rostami, 2015. Synthesis and characterization of chitosan coated manganese zinc ferrite nanoparticles as MRI contrast agents. J. Nanostruct., 5: 77-86.
    CrossRef  |  Direct Link  |  
  57. Shahbazi-Gahrouei, D., M. Gholami, T.A. Pourfallah and M. Keshtkar, 2015. Does nitrogen gas bubbled through a low density polymer gel dosimeter solution affect the polymerization process? Adv. Biomed. Res., Vol. 4. 10.4103/2277-9175.156651.
    CrossRef  |  Direct Link  |  
  58. Shahbazi-Gahrouei, D., A. Gookizadeh, M. Sohrabi and Z. Arab, 2015. Normal tissues absorbed dose and associated risk in breast radiotherapy. J. Radiobiol., 2: 20-21.
  59. Shahbazi-Gahrouei, D. and S. Ayat, 2015. Determination of organ doses in radioiodine therapy using Monte Carlo simulation. World J. Nuclear Med., 14: 16-18.
    CrossRef  |  Direct Link  |  
  60. Shahbazi-Gahrouei, D. and F. Aminolroayaei, 2015. Investigating the entrance surface and collective doses for radiographic examination in neonatal intensive care unit. J. Isfahan Med. Sch., 33: 1730-1739.
  61. Maziar, A., D. Shahbazi-Gahrouei, M.B. Tavakoli and V. Changizi, 2015. Non invasive XRF analysis of human hair for health state determination of breast tissue. Iran. J. Cancer Prev., Vol. 8. 10.17795/ijcp-3983.
    CrossRef  |  Direct Link  |  
  62. Gholami, M., D. Shahbazi-Gahrouei and T.A. Pourfallah, 2015. Dose response evaluation of a low density anoxic polymer gel dosimeter using MRI. Int. J. Radiat. Res., 13: 243-249.
    Direct Link  |  
  63. Ghasemian, Z., D. Shahbazi-Gahrouei and S. Manouchehri, 2015. Cobalt zinc ferrite nanoparticles as a potential magnetic resonance imaging agent: An in vitro study. Avicenna J. Med. Biotechnol., 7: 64-68.
    PubMed  |  Direct Link  |  
  64. Arab-Bafrani, Z., A.H. Saberi, M.J.T. Birgani, D. Shahbazi-Gahrouei, M. Abbasian and M. Fesharaki, 2015. Gold nanoparticle and mean inactivation dose of human intestinal colon cancer HT-29 cells. Jundishapur J. Nat. Pharm. Prod., Vol. 10. 10.17795/jjnpp-29153.
    CrossRef  |  
  65. Arab-Bafrani, Z. and D. Shahbazi-Gahrouei, 2015. Optical, physical and quantum properties of gold nanoparticles and its applications in diagnosis and treatment of cancers. J. Isfahan Med. Sch., 33: 160-170.
  66. Akmali, Z., D. Shahbazi-Gahrouei, M.A.M. Shirazi, M. Baradaran-Ghahfarokhi, N. Fallahian and S. Sherkat, 2015. Design and fabrication of a 4-dimensional of respiratory phantom for studying tumor movement in radiotherapy by MR imaging. J. Isfahan Med. Sch., 33: 631-642.
  67. Ahmadi, Z., D. Shahbazi-Gahrouei, B. Hashmi-Beni and M. Karbalaee, 2015. Effects of exposure to 900 MHz mobile telephony radiation on growth and metabolism of human-Adipose-derived stem cells. J. Isfahan Med. Sch., 32: 2268-2278.
  68. Shahbazi Gahrouei, D., M. Damoori, M.B. Tavakoli, M. Moslehi and S. Rastaghi, 2015. Estimating the absorbed doses from 99mTc -MDP in patients following bone scan. J. Isfahan Med. Sch., 33: 1628-1636.
  69. Shahbazi-Gahrouei, D., S. Razavi and M. Salimi, 2014. Effect of extremely low-frequency (50 Hz) field on proliferation rate of human adipose-derived mesenchymal stem cells. J. Radiobiol., 1: 31-37.
    Direct Link  |  
  70. Shahbazi-Gahrouei, D., S. Leila, A. Hojjatollah, N. Naser and K. Saeed et al., 2014. The effect of extremely low- frequency magnetic fields on the level of serotonin metabolite in the Raphe nuclei of adult male rat. J. Isfahan Med. Sch., 32: 1354-1362.
  71. Shahbazi-Gahrouei, D., M. Karbalae, H. Moradi and M. Baradaran-Ghahfarokhi, 2014. Health effects of living near mobile phone Base Transceiver Station (BTS) antennae: A report from Isfahan, Iran. Electromagn. Biol. Med., 33: 206-210.
    CrossRef  |  Direct Link  |  
  72. Shahbazi-Gahrouei, D., 2014. Radiobiological modeling in radiation oncology. J. Radiobiol., 1: 17-18.
    Direct Link  |  
  73. Shahbazi-Gahrouei, D. and M. Abdolahi, 2014. Investigation of association between high background radiation exposure with trace element concentrations' (copper, zinc, iron and magnesium) of hot springs workers blood in Mahalat. Iran. South Med. J., 17: 687-694.
    Direct Link  |  
  74. Razavi, S., M. Salimi, D. Shahbazi-Gahrouei, S. Karbasi and S. Kermani, 2014. Extremely low-frequency electromagnetic field influences the survival and proliferation effect of human adipose derived stem cells. Adv. Biomed. Res., Vol. 3. 10.4103/2277-9175.124668.
    CrossRef  |  PubMed  |  Direct Link  |  
  75. Nasri, H., P. Nasri, M. Baradaran-Ghahfarokhi, D. Shahbazi-Gahrouei and J. Fattahi-Asl, 2014. Mobile phone radiation and human serum components: A short literature review on recent findings. Life Sci. J., 11: 426-431.
    Direct Link  |  
  76. Dastjerdi, F.N., D. Shahbazi-Gahrouei, M.H. Alamatsaz, M. Khosravi and M. Baradaran-Ghahfarokhi, 2014. Photoneutron shielding design for an 18 MV Saturne 20 medical linear accelerator. J. Isfahan Med. Sch., 32: 1433-1443.
  77. Shahbazi-Gahrouei, D., Z. Ghasemian, M. Abdolahi, S. Manouchehri, S.H. Javanmard and N. Dana, 2013. In vitro evaluation of cobalt-zinc ferrite nanoparticles coated with DMSA on human prostate cancer cells. Mol. Biomarkers Diagn., Vol. 4, No. 3. 10.4172/2155-9929.1000154.
    CrossRef  |  Direct Link  |  
  78. Shahbazi-Gahrouei, D., S. Setayandeh and M. Gholami, 2013. A review on comparison of natural radiation in Iran with other countries. Int. J. Low Radiat., 9: 1-11.
    CrossRef  |  Direct Link  |  
  79. Shahbazi-Gahrouei, D., S. Manouchehri, Z. Ghasemian and M. Abdolahi, 2013. Synthesis and characterization of Cobalt-zinc ferrite magnetic nanoparticles coated with DMSA. Proceedings of the 30th ESMRMB Annual Scientific Meeting, October 3-5, 2013, Toulouse, France, pp: 602-.
  80. Shahbazi-Gahrouei, D., M. Gholami and S. Setayandeh, 2013. A review on natural background radiation. Adv. Biomed. Res., Vol. 2. 10.4103/2277-9175.115821.
    CrossRef  |  PubMed  |  Direct Link  |  
  81. Shahbazi-Gahrouei, D., M. Cheki and M. Moslehi, 2013. Assessment of organ absorbed dose in patients following bone scan with technetium-99m-labeled Methylene Diphosphonate (MDP) using of MIRD method. Proceeding of the Annual Congress of the European Association of Nuclear Medicine, October 19-23, 2013, Lyon, France, pp: 426-.
  82. Shahbazi-Gahrouei, D., F. Koohian and M. Koohian, 2013. Changes of cortisol and glucose concentrations in rats exposed to MR imaging field. J. Biomed. Phys. Eng., 3: 9-12.
    Direct Link  |  
  83. Shahbazi-Gahrouei, D. and M. Baradaran-Ghahfarokhi, 2013. Assessment of entrance surface dose and cancer risk from common radiology examinations in Iran. Radiat. Protect. Dosimetry, 154: 308-313.
  84. Shahbazi-Gahrouei, D. and M. Abdolahi, 2013. Superparamagnetic iron oxide-monoclonal antibody: Potential MR imaging contrast agents for ovarian cancer. Proceedings of the 30th ESMRMB Annual Scientific Meeting, October 3-5, 2013, Toulouse, France, pp: 496-.
  85. Shahbazi-Gahrouei, D. and M. Abdolahi, 2013. Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection. J. Med. Phys., 38: 198-204.
    CrossRef  |  PubMed  |  Direct Link  |  
  86. Shahbazi-Gahrouei, D. and M. Abdolahi, 2013. Detection of MUC1-expressing ovarian cancer by C595 monoclonal antibody-conjugated SPIONs using MR imaging. Scient. World J. 10.1155/2013/609151.
    CrossRef  |  Direct Link  |  
  87. Shahbazi-Gahrouei D., M. Abdolahi, S.H. Zarkesh, S. Laurent, C. Sermeus and C. Gruettner, 2013. Functionalized magnetic nanoparticles for the detection and quantitative analysis of cell surface antigen. BioMed. Res. Int. 10.1155/2013/349408.
    CrossRef  |  PubMed  |  Direct Link  |  
  88. Salimi, M., D. Shahbazi-Gahrouei, S. Karbasi, S. Kermani and S. Razavi, 2013. Effect of extremely low-frequency (50 Hz) field on proliferation rate of human adipose-derived mesenchymal stem cells. J. Isfahan Med. School, 31: 1-17.
  89. Moslehi, M., M. Rahimi, B.M. Khaniabadi and D. Shahbazi-Gahrouei, 2013. The effect of neck physical examination and signing thyroid nodules by lead marker on 99mTcO4 thyroid scan results. J. Isfahan Med. School, 31: 1797-1805.
    Direct Link  |  
  90. Mirzaei, M., D. Shahbazi-Gahrouei and M. Mohagheghi, 2013. Synthesis and development of Gd3+-ALGDG2-C595 as MR imaging contrast agent. J. Biomater. Nanobiotechnol., 4: 22-29.
    CrossRef  |  Direct Link  |  
  91. Manouchehri, S., Z. Ghasemian, D. Shahbazi-Gahrouei and M. Abdolahi, 2013. Synthesis and characterization of cobalt-zinc ferrite nanoparticles coated with DMSA. ChemXpress, 2: 147-152.
    Direct Link  |  
  92. Khosravi, M., D. Shahbazi-Gahrouei, K. Jabbari, M. Baradaran-Ghahfarokhi, R. Gheisari and B. Amiri, 2013. Photoneutron contamination from an 18 MV Saturne medical linear accelerator in treatment room: Monte-Carlo simulation. Radiat. Protect. Dosimetry, 156: 356-363.
  93. Cheki, M., D. Shahbazi-Gahrouei and M. Moslehi, 2013. Determination of organ absorbed doses in patients following bone scan with using of MIRD method. Iran. South Med. J., 16: 296-303.
    Direct Link  |  
  94. Abdolahi, M., D. Shahbazi-Gahrouei, S. Laurent, C. Sermeus and F. Firozan et al., 2013. Synthesis and In vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer. Contrast Media Mol. Imaging, 8: 175-184.
    CrossRef  |  Direct Link  |  
  95. Shahbazi-Gahrouei, D., S.M.J. Mortazavi, H. Nasri, A. Baradaran, M. Baradaran-Ghahfarokhi and H.R. Baradaran-Ghahfarokhi, 2012. Mobile phone radiation interferes laboratory immunoenzymometric assays: Example chorionic gonadotropin assays. Pathophysiology, 19: 43-47.
    CrossRef  |  Direct Link  |  
  96. Shahbazi-Gahrouei, D., M. Khosravi, K. Jabbari and R. Gheisari, 2012. Measurement of photoneutron dose in the linear accelerator at the radiation therapy section of Seyed-Al-Shohada hospital, Isfahan, Iran. J. Isfahan Med. School, 29: 1-10.
    Direct Link  |  
  97. Shahbazi-Gahrouei, D., M. Cheki and M. Moslehi, 2012. Estimation of organ absorbed doses in patients from 99mTc-diphosphonate using the data of MIRDose software. J. Med. Signals Sensors, 2: 231-233.
    Direct Link  |  
  98. Shahbazi-Gahrouei, D. and S. Ayat, 2012. Comparison of three methods of calculation, experimental and Monte Carlo simulation in investigation of organ doses (thyroid, sternum, cervical vertebra) in radioiodine therapy. J. Med. Signals Sensors, 2: 149-152.
    Direct Link  |  
  99. Shahbazi-Gahrouei, D. and M. Baradaran-Ghahfarokhi, 2012. Investigation of patient dose from common radiology examinations in Isfahan, Iran. Adv. Biomed. Res., Vol. 1. 10.4103/2277-9175.96064.
    CrossRef  |  PubMed  |  Direct Link  |  
  100. Shahbazi-Gahrouei, D. and M. Abdolahi, 2012. The correlation between high background radiation and blood level of the trace elements (copper, zinc, iron and magnesium) in workers of Mahallat's hot springs. Adv. Biomed. Res., Vol. 1. 10.4103/2277-9175.100190.
    CrossRef  |  PubMed  |  Direct Link  |  
  101. Shahbazi-Gahrouei, D. and M. Abdolahi, 2012. A novel method for quantitative analysis of anti-MUC1 expressing ovarian cancer cell surface based on magnetic cell separation. J. Med. Sci., 12: 256-266.
    CrossRef  |  Direct Link  |  
  102. Mosleh-Shirazi, M.A., S. Karbasi, D. Shahbazi-Gahrouei and S. Monadi, 2012. A Monte Carlo and experimental investigation of the dosimetric behavior of low- and medium-perturbation diodes used for entrance in vivo dosimetry in megavoltage photon beams. J. Applied Clin. Med. Phys., 13: 326-338.
    Direct Link  |  
  103. Mirzaei, M., M. Mohagheghi, D. Shahbazi-Gahrouei and A. Khatami, 2012. Novel nanosized Gd3+-ALGD-G2-C595: In vivo dual selective MUC-1 positive tumor molecular MR imaging and therapeutic agent. J. Nanomed. Nanotechnol., Vol. 3, No. 7. 10.4172/2157-7439.1000147.
    CrossRef  |  Direct Link  |  
  104. Mirzaei, M., M. Mohagheghi, D. Shahbazi-Gahrouei and A. Khatami, 2012. Gd3+-anionic linear globular dendrimer-G2-C595 a novel nanoprobe for MR imaging: An in vitro study. J. Biomol. Res. Therapeut., Vol. 1, No. 2. 10.4172/2167-7956.1000103.
    CrossRef  |  Direct Link  |  
  105. Fatahian, S., D. Shahbazi-Gahrouei, M. Pouladian, M.H. Yousefi, G.R. Amiri and A. Noori, 2012. Biodistribution and toxicity assessment of radiolabeled and DMSA coated ferrite nanoparticles in mice. J. Radioanal. Nuclear Chem., 293: 915-921.
    CrossRef  |  Direct Link  |  
  106. Shahbazi-Gahrouei, D., M. Nazem, M. Sharbafchizadeh and M.S. Jafarpishehfard, 2011. The average of cumulative radiation dose in neonates in the neonatal surgery ward due to diagnostic and therapeutic radiologic procedures during the admission period. J. Isfahan Med. School, 29: 626-633.
    Direct Link  |  
  107. Shahbazi-Gahrouei, D., M. Abdolahi, F. Hasanzadeh, F. Firouzian, S. Zarkesh and B.J. Allen, 2011. Detection of PSMA-expressing prostate cancer by J591 Mab-conjugated SPIONs using MRI. Proceedings of the 1st MEFOMP International Conference of Medical Physics, November 2-4, 2011, Shiraz, Iran -.
  108. Shahbazi-Gahrouei, D., F. Kouhian, M. Kouhian and M. Sadeghi, 2011. Effects of MRI on sex hormones and other fertility parameters in adult male rats. J. Shahrekord Univ. Med. Sci., 13: 35-41.
    Direct Link  |  
  109. Shahbazi-Gahrouei, D., 2011. Non-ionizing radiation and health hazards. Proceedings of the 1st MEFOMP International Conference of Medical Physics, November 2-4, 2011, Shiraz, Iran -.
  110. Shahbazi-Gahrouei, D. and S. Nikzad, 2011. Determination of organ doses in radioiodine therapy using Medical Internal Radiation Dosimetry (MIRD) method. Iran. J. Radiat. Res., 8: 249-252.
    Direct Link  |  
  111. Shahbazi-Gahrouei, D. and S. Ayat, 2011. Comparison of three methods of calculation, experimental and Monte Carlo simulation in investigation of organ doses (thyroid, sternum, cervical vertebra) in radioiodine therapy. Proceedings of the 1st MEFOMP International Conference of Medical Physics, November 2-4, 2011, Shiraz, Iran -.
  112. Shahbazi-Gahrouei, D. and M. Salimi-Afjani, 2011. The application of Excimer laser in refractive errors correction and compared with glasses and contact lens. Proceedings of the 1st MEFOMP International Conference of Medical Physics, November 2-4, 2011, Shiraz, Iran -.
  113. Kouhiyan, F., D. Shahbazi and M. Kouhiyan, 2011. Change of cortisol concentration in rats exposed to magnetic resonance imaging. Proceedings of the 1st MEFOMP International Conference of Medical Physics, November 2-4, 2011, Shiraz, Iran -.
  114. Fatahian, S., D. Shahbazi-Gahrouei, M. Pouladain, M.H. Yousefi, G.R. Amiri, Z. Shahi and H. Jahanbakhsh, 2011. Preparation and magnetic properties investigation of Fe3O4 nanoparticles 99mTc labeled and Fe3O4 nanoparticles DMSA coated. Digest J. Nanomater. Biostruct., 6: 1161-1165.
    Direct Link  |  
  115. Shahbazi-Gahrouei, D., 2010. The effect of diagnostic magnetic fields (0.35 T) on sex hormones and other fertility parameters of adult male rats. Proceedings of the 6th International Workshop on Biological Effects of Electromagnetic Fields, October 10-14, 2010, Bodrum, Turkey -.
  116. Shahbazi-Gahrouei, D. and S. Nikzad, 2010. Determination of organ doses in radioiodine therapy using Medical Internal Radiation Dosimetry (MIRD) method. Proceedings of the International Conference on Radiation Protection in Medicine, September 1-3, 2010, Varna, Bulgaria -.
  117. Shahbazi-Gahrouei, D. and M. Abdolahi, 2010. Investigation of relationship between background exposure with trace element concentrations of hot springs workers in Mahalat. Proceedings of the 1st Research Festival of the Student Radiological Sciences, October 7-8, 2010, Shiraz University of Medical Sciences, Iran -.
  118. Amiri, G.R., M.H. Yousefi, M.R. Aboulhassani, M.H. Keshavarz, D. Shahbazi-Gahrouei, S. Fatahian and M. Alahi, 2010. Radar Absorption and Q-Factor of Ni0.7Zn0.3Fe2O4 nanoparticles. Digest J. Nanomater. Biostruct., 5: 719-725.
    Direct Link  |  
  119. Shahbazi-Gahrouei, D., S. Nikzad, P. Shokrani, Z. Shahi and S. Monadi, 2009. Determination of absorbed dose of organs (thyroid, sternum, cervical vertebra) in thyroid cancer patients following Radioiodine therapy. Iran. J. Nuclear Med., 17: 27-33.
    Direct Link  |  
  120. Shahbazi-Gahrouei, D., P. Bonyadi, M. Moslehi and Z. Shahi, 2009. Effects of early liothyronine consumption after radioiodine therapy on accumulated dose and exposure rate in patients with thyroid carcinoma. Iran. J. Nuclear Med., 16: 8-15.
    Direct Link  |  
  121. Shahbazi-Gahrouei, D., A. Arabpour, F. Rastgoo and N. Yaghoobi, 2009. Comparison of reconstructive methods using different filters to study cardiac wall motions in gated single photon emission computerized tomography. J. Applied Sci., 9: 312-319.
    CrossRef  |  Direct Link  |  
  122. Shahbazi-Gahrouei, D., 2009. Novel MR imaging contrast agents for cancer detection. Proceedings of the 26th ESMRMB Annual Scientific Meeting, October 1-3, 2009, Antalya, Turkey -.
  123. Shahbazi-Gahrouei, D., 2009. Novel MR imaging contrast agents for cancer detection. J. Res. Med. Sci., 14: 141-147.
    PubMed  |  Direct Link  |  
  124. Shahbazi-Gahrouei, D., 2009. Determination of absorbed dose of organs (thyroid, sternum, neck vertebra) in thyroid cancer patients under iodine therapy. Proceedings of the World Congress on Medical Physics and Biomedical Engineering, September 7-12, Munich, Germany -.
  125. Mosleh-Shirazi, M.A., D. Shahbazi-Gahrouei, S. Karbasi and S. Monadi, 2009. Characterization and Monte Carlo simulation of low- and high-perturbation in-vivo diode dosimeters for 9 MV X-rays. IFMBE Proc., 25: 731-734.
    CrossRef  |  Direct Link  |  
  126. Kermani, S., M.H. Moradi, H. Abrishami-Moghaddam, H. Saneei, M.J. Marashi and D. Shahbazi-Gahrouei, 2009. Quantitative analysis of left ventricular performance from sequences of cardiac magnetic resonance imaging using active mesh model. Comput. Med. Imaging Graph., 33: 222-234.
    CrossRef  |  Direct Link  |  
  127. Shahbazi-Gahrouei, D., A. Gookizadeh, M. Abdollahi and Z. Shahi, 2008. Comparison of conventional radiotherapy techniques with different energies of prostate cancer treatment, using a designed pelvis phantom. Proceedings of the 6th Congress of the Iranian Radiographic Sciences Association, April 25-26, 2008, Shiraz, Iran -.
  128. Shahbazi-Gahrouei, D., A. Ebrahiminia and A. Karegar, 2008. Investigation of relationship between exposure with trace element concentrations of radiation workers in Isfahan. Proceedings of the 6th Congress of the Iranian Radiographic Sciences Association, April 25-26, 2008, Shiraz, Iran -.
  129. Shahbazi-Gahrouei, D., A. Arabpour, S. Kermani and F. Rastgoo, 2008. Assessment of gated single photon emission computerized tomography cardiac wall motion by using different reconstruction methods and filters in comparison with quantitative coronary angiography. J. Med. Sci., 8: 342-349.
    CrossRef  |  Direct Link  |  
  130. Shahbazi-Gahrouei, D. and Z. Shahi, 2008. Novel MR imaging contrast agents for cancer detection. Proceedings of the 6th Congress of the Iranian Radiographic Sciences Association, April 25-26, 2008, Shiraz, Iran -.
  131. Shahbazi-Gahrouei, D. and M. Saeb, 2008. Dose assessment and radioactivity of the mineral water resources of Dimeh springs in Chaharmahal and Bakhtiari province, Iran. Nukleonika, 53: 31-34.
    Direct Link  |  
  132. Shahbazi-Gahrouei, D. and M. Saeb, 2008. Annual effective dose measurement from consumption of Dimeh springs in the highest altitude region of Iran. Int. J. Low Radiat., 5: 49-54.
    CrossRef  |  Direct Link  |  
  133. Shahbazi, D., A. Gookizadeh and M. Abdollahi, 2008. Comparison of conventional radiotherapy techniques with different energies in treating prostate cancer, employing a designed pelvis phantom. J. Med. Sci., 8: 429-432.
    CrossRef  |  Direct Link  |  
  134. Raeisi, E., H. Rajabi, D. Shahbazi-Gahrouei, S.M.R Aghamiri and Z. Shahi, 2008. Quality control tests for single-head gamma camera. Proceedings of the 6th Congress of the Iranian Radiographic Sciences Association, April 25-26, 2008, Shiraz, Iran -.
  135. Ebrahiminia, A., D. Shahbazi-Gahrouei, A. Karegar and A. Farzan, 2008. Relationship between occupational exposure and concentration of some trace elements in radiology and radiotherapy workers. J. Qazvin Univ. Med. Sci., 12: 52-57.
    Direct Link  |  
  136. Tavakoli, M.B., D. Shahbazi-Gahrouei and M. Hosseinpour, 2007. Dosimetric characteristics of 137Cs sources used in after loading Selectron system by Monte Carlo method. Iran. J. Radiat. Res., 5: 147-152.
    Direct Link  |  
  137. Shahbazi-Gahrouei, D., Z. Shahi, K. Ziaei and E. Khodamoradi, 2007. Estimation of absorbed dose of salivary glands in radioiodine therapy and its reduction using pilocarpine. Iran. J. Nuclear Med., 15: 1-8.
    Direct Link  |  
  138. Shahbazi-Gahrouei, D., Z. Shahi and K. Ziaei, 2007. Dose assessment of salivary glands in radioiodine therapy. Proceeding of the Annual Congress of the European Association of Nuclear Medicine, October 13-17, 2007, Copenhagen, Denmark, pp: S359-.
  139. Shahbazi-Gahrouei, D. and E. Khodamoradi, 2007. Porphyrin-based agents: Potential MR imaging contrast agents for colorectal (HT29/219) detection in mice. J. Med. Sci., 7: 1015-1020.
    CrossRef  |  Direct Link  |  
  140. Shahbazi-Gahrouei, D. and E. Khodamoradi, 2007. Novel MR imaging contrast agents for detection of HT29/219 cells in mice. Proceedings of the Joint Annual Meeting ISMRM-ESMRMB, May 19-25, 2007, Berlin, Germany -.
  141. Mehri, A.R., D. Shahbazi-Gahrouei and L. Ghaedi, 2007. Investigation and comparison of recording time of steady state evoked potentials using three methods of Kalman, Ziarani and adaptive. Audiology, 16: 18-24.
    Direct Link  |  
  142. Shahbazi-Gahrouei, D., M.B. Tavakoli, M. Roufeh and V. Nazari, 2006. Assessment of new Gadolinium compounds as contrast agents for detection of MCF-7 breast cancer cell line in MRI. Feyz Mag., 10: 16-21.
    Direct Link  |  
  143. Shahbazi-Gahrouei, D., M. Roufeh and M.B. Tavakoli, 2006. Gd DTPA-C595 as a new MR imaging contrast agents for breast cancer (MCF-7) detection. Proceedings of the 23rd ESMRMB Annual Scientific Meeting, September 21-23, 2006, Warsaw, Poland -.
  144. Shahbazi-Gahrouei, D., M. Roufeh and M.B. Tavakoli, 2006. Gadolinium-diethylenetriaminepenta-acetic acid conjugated with monoclonal antibody C595 as new magnetic resonance imaging contrast agents for breast cancer (MCF-7) detection. Iran. Biomed J., 10: 209-213.
    Direct Link  |  
  145. Shahbazi-Gahrouei, D., 2006. Gadolinium-porphyrins: New potential magnetic resonance imaging contrast agents for melanoma detection. J. Res. Med. Sci., 11: 217-223.
    Direct Link  |  
  146. Shahbazi-Gahrouei, D., 2006. Entrance surface dose measurements for routine X-ray examinations in Chaharmahal and Bakhtiari hospitals. Iran. J. Radiat. Res., 4: 29-33.
    Direct Link  |  
  147. Shahbazi-Gahrouei, D. and M.B. Tavakoli, 2006. Gd-DTPA-C595 as a new MR imaging contrast agents for breast cancer (MCF-7) detection. Proceedings of the 23rd ESMRMB Annual Scientific Meeting, September 21-23, 2006, Warsaw, Poland -.
  148. Bouzarjomehri, F.A., M.H. Zare and D. Shahbazi-Gahrouei, 2006. Conventional and spiral CT dose indices in Yazd general hospitals, Iran. Iran. J. Radiat. Res., 3: 183-189.
    Direct Link  |  
  149. Bouzarjomehri, F., M.H. Zare and D. Shahbazi-Gahrouei, 2006. Patient dose resulting from CT examinations in Yazd, Iran. Iran. J. Radiat. Res., 4: 121-127.
    Direct Link  |  
  150. Shahbazi-Gahrouei, D., M.B. Tavakoli and V. Nazari, 2005. Gadolinium-hematoporphyrin: New potential MRI contrast agent for detection of breast cancer cell line (MCF-7). J. Res. Med. Sci., 10: 309-313.
    Direct Link  |  
  151. Shahbazi-Gahrouei, D., 2005. Gadolinium-hematoporphyrins as potential MR imaging contrast agents for detection of breast cancer cell line (MCF-7). Proceedings of the 22nd Annual ESMRMB Meeting, September 15-18, 2005, Basle, Switzerland -.
  152. Behroozkia, Z. and D. Shahbazi-Gahrouei, 2005. The rate of exposure of patients in common X-ray examinations in radiology centers of Chaharmahal and Bakhtiari province. J. Shahrekord Univ. Med. Sci., 7: 57-63.
    Direct Link  |  
  153. Shahbazi-Gahrouei, D., 2004. Quality control of the radiological equipment in Chaharmahal and Bakhtiari hospitals. J. Shahrekord Univ. Med. Sci., 5: 11-18.
    Direct Link  |  
  154. Shahbazi-Gahrouei, D., 2004. Investigation of Gd-DTPA-9.2.27 monoclonal antibody and porphyrin compounds as cancer-specific MR imaging contrast agents. Proceedings of the ESMRMB 21st Annual Scientific Meeting, September 9-12, 2004, Copenhagen, Denmark -.
  155. Shahbazi-Gahrouei, D. and D. Azar, 2004. Investigation of cancers incidence relevant to radiation in Chaharmahal and Bakhtiari province during five years (1998-2002). J. Shahrekord Univ. Med. Sci., 6: 7-13.
    Direct Link  |  
  156. Shahbazi-Gahrouei, D., 2003. Possible effect of background radiation on cancer incidence in Chaharmahal and Bakhtiari province. Iran. J. Radiat. Res., 1: 171-174.
    Direct Link  |  
  157. Shahbazi-Gahrouei, D., 2003. New metalloporphyrins as potential MR imaging contrast agents for tumor detection. Proceedings of the ISMRM 11th Scientific Meeting and Exhibition, July 10-16, 2003, Toronto, Ontario, Canada -.
  158. Shahbazi-Gahrouei, D., 2003. Natural background radiation dosimetry in the highest altitude region of Iran. J. Radiat. Res., 44: 285-287.
    PubMed  |  
  159. Shahbazi-Gahrouei, D., 2003. Annual background radiation in Chaharmahal and Bakhtiari province. Iran. J. Radiat. Res., 1: 87-91.
    Direct Link  |  
  160. Shahbazi-Gahrouei, D., M. Williams, S.M. Rizvi and B.J. Allen, 2002. In vitro studies of gadolinium-DTPA conjugated with monoclonal antibodies as cancer-specific magnetic resonance imaging contrast agents. Australasian Phys. Eng. Sci. Med., 25: 31-38.
    CrossRef  |  PubMed  |  Direct Link  |  
  161. Shahbazi-Gahrouei, D., 2002. Measurement of natural background radiation in Chaharmahal and Bakhtiari province. J. Shahrekord Univ. Med. Sci., 4: 21-26.
    Direct Link  |  
  162. Shahbazi-Gahrouei, D. and B.J. Allen, 2002. New gadolinium-porphyrins: Potential MR imaging contrast agents for cancer detection in nude mice. Proceedings of the 19th ESMRMB Annual Scientific Meeting, August 22-25, 2002, Cannes, France, pp: 409-.
  163. Shahbazi-Gahrouei, D. and B.J. Allen, 2002. New gadolinium complexes as tumor-specific MR imaging contrast agents for cancer detection in nude mice. Proceedings of the 10th ISMRM Meeting, May 18-24, 2002, Honolulu, HI., USA., pp: 2176-.
  164. Behroozkia, Z. and D. Shahbazi-Gahrouei, 2002. Comparison of prescribed and absorbed doses in solid phantom treatment fields of body in patients with Hodgkin and uterine adenocarcinoma. J. Shahrekord Univ. Med. Sci., 4: 9-16.
    Direct Link  |  
  165. Shahbazi-Gahrouei, D., M. Williams, S. Rizvi and B.J. Allen, 2001. In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: Potential magnetic resonance imaging contrast agents for melanoma. J. Magn. Resonance Imaging, 14: 169-174.
    CrossRef  |  Direct Link  |  
  166. Shahbazi-Gahrouei, D., M. Williams and B.J. Allen, 2001. Synthesis and application of new gadolinium-porphyrins as potential MR imaging contrast agents for cancer detection in nude mice. Iran. Biomed. J., 5: 87-95.
    Direct Link  |  
  167. Shahbazi-Gahrouei, D., 2001. Targeted alpha therapy using radiolabeling of monoclonal antibody. J. Shahrekord Univ. Med. Sci., 3: 1-8.
    Direct Link  |  
  168. Shahbazi‐Gahrouei, D., M. Williams and B.J. Allen, 2001. In vitro study of relationship between signal intensity and gadolinium-DTPA concentration at high magnetic field strength. Australasian Radiol., 45: 298-304.
    CrossRef  |  Direct Link  |  
  169. Shahbazi-Gahrouei, D., M. Williams, S. Rizvi and B.J. Allen, 2000. Gadolinium-cDTPAa conjugated with melanoma monoclonal antibody 9.2.27 as a melanoma specific MRI contrast agent. Proceedings of the 8th ISMRM Meeting, April 1-7, 2000, Denver, Colorado, USA., pp: 2604-.
    Direct Link  |  
  170. Shahbazi-Gahrouei, D., 2000. Investigation of relationship between MR imaging, signal intensity and contrast agent at high magnetic field strength. J. Shahrekord Univ. Med. Sci., 2: 1-9.
    Direct Link  |